Pro- or anti-inflammatory properties of the adipokine dipeptidyl peptidase-4?
Linhua
L
Xu
Giatgen A
GA
Spinas
Markus
M
Niessen
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D010190:Pancreatic Neoplasms / Q000139:chemically induced*; D010195:Pancreatitis / Q000139:chemically induced*; D010455:Peptides / Q000009:adverse effects*; D011719:Pyrazines / Q000009:adverse effects*; D018027:Receptors, Glucagon / Q000819:agonists*; D013964:Thyroid Neoplasms / Q000139:chemically induced*; D014230:Triazoles / Q000009:adverse effects*; D014688:Venoms / Q000009:adverse effects*
D054873:Dipeptidyl-Peptidase IV Inhibitors; D007004:Hypoglycemic Agents; D010455:Peptides; D011719:Pyrazines; D018027:Receptors, Glucagon; D014230:Triazoles; D014688:Venoms